Form D Explorer

Inspect source fieldsReport a record issue

Form D — Alto Neuroscience, Inc.

0001231919-25-000357 · filed Oct 27, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Pharmaceuticals filings

Offering

Industry
Pharmaceuticals
Exemptions
Rule 506(b)
Reported offering amount
$49,999,533
Reported amount sold
$49,999,533
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
Alto Neuroscience, Inc.
CIK
1999480
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
—
Address
650 CASTRO STREET, SUITE 450
MOUNTAIN VIEW, California 94041
Phone
(650) 200-0412

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

View the original filing on SEC EDGAR ↗